209 related articles for article (PubMed ID: 29424507)
1. Do we have enough evidences that make you safe to treat a man with hypogonadism one year after a radical prostatectomy for prostate cancer? | Opinion: Not Yet.
Wroclawski ML; Heldwein FL
Int Braz J Urol; 2018; 44(1):8-13. PubMed ID: 29424507
[No Abstract] [Full Text] [Related]
2. Do we have enough evidences that make you safe to treat a man with hypogonadism one year after a radical prostatectomy for prostate cancer? | Opinion: YES.
Torres LO
Int Braz J Urol; 2018; 44(1):4-7. PubMed ID: 29424506
[No Abstract] [Full Text] [Related]
3. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer.
Meza J; Weaver K; Martin S
Am Fam Physician; 2013 Oct; 88(8):Online. PubMed ID: 24364582
[No Abstract] [Full Text] [Related]
4. [Testosterone substitution therapy in prostate cancer].
Kaminsky A; Sperling H
Urologe A; 2011 Aug; 50(8):977-84. PubMed ID: 21811932
[TBL] [Abstract][Full Text] [Related]
5. [Testosterone replacement therapy for hypogonadism in men with prostate cancer].
Jensen CF; Fode M; Østergren P; Sønksen J
Ugeskr Laeger; 2017 Feb; 179(9):. PubMed ID: 28263152
[TBL] [Abstract][Full Text] [Related]
6. [Hypogonadism - testosterone replacement therapy after prostate cancer?].
van Essen J; Pfister D; Heidenreich A
Aktuelle Urol; 2014 Jan; 45(1):17-8. PubMed ID: 24500954
[No Abstract] [Full Text] [Related]
7. Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.
Kaufman JM; Graydon RJ
J Urol; 2004 Sep; 172(3):920-2. PubMed ID: 15310998
[TBL] [Abstract][Full Text] [Related]
8. [Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?].
Castillo OA; López-Fontana G; Vidal-Mora I; López Laur JD
Medwave; 2015 Apr; 15(3):e6115. PubMed ID: 25919660
[TBL] [Abstract][Full Text] [Related]
9. [Testosterone replacement therapy for late-onset hypogonadism after radical prostatectomy: a case report].
Nakano K; Kiuchi H; Miyagawa Y; Tsujimura A; Nonomura N
Hinyokika Kiyo; 2014 Aug; 60(8):397-400. PubMed ID: 25179991
[TBL] [Abstract][Full Text] [Related]
10. The role of testosterone replacement therapy following radical prostatectomy.
Khera M; Lipshultz LI
Urol Clin North Am; 2007 Nov; 34(4):549-53, vi. PubMed ID: 17983894
[TBL] [Abstract][Full Text] [Related]
11. [Testosterone and the prostate].
Sperling H; Rossi R; Lümmen G; Rübben H
Urologe A; 2004 Sep; 43(9):1092-6. PubMed ID: 15368045
[TBL] [Abstract][Full Text] [Related]
12. Testosterone replacement therapy. A rush to judgment?
Loughlin KR
J Urol; 2004 Sep; 172(3):827-8. PubMed ID: 15310977
[No Abstract] [Full Text] [Related]
13. [Prostate Cancer Diagnosed during Androgen Replacement Therapy for Late-Onset Hypogonadism Treatment: A Case Report].
Sunada T; Hama Y; Ikeuchi R; Funada S; Masuda N; Yoshikawa T; Yoshida T; Hataya Y; Komatsu Y; Segawa T
Hinyokika Kiyo; 2018 Dec; 64(12):501-504. PubMed ID: 30831666
[TBL] [Abstract][Full Text] [Related]
14. The uses and misuses of testosterone therapy.
Johns Hopkins Med Lett Health After 50; 2006 Aug; 18(6):3, 7. PubMed ID: 16921650
[No Abstract] [Full Text] [Related]
15. Testosterone Treatment of Men with Unequivocal Hypogonadism Following Treatment of Organ-Confined Prostate Cancer.
Jones RB; Snyder PJ
Endocr Pract; 2023 Sep; 29(9):723-726. PubMed ID: 37236354
[TBL] [Abstract][Full Text] [Related]
16. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
Gould DC; Kirby RS
Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
[TBL] [Abstract][Full Text] [Related]
17. The Role of Testosterone Therapy in the Setting of Prostate Cancer.
Rodriguez KM; Pastuszak AW; Khera M
Curr Urol Rep; 2018 Jun; 19(8):67. PubMed ID: 29961247
[TBL] [Abstract][Full Text] [Related]
18. Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes.
Kaplan AL; Hu JC
Urology; 2013 Aug; 82(2):321-6. PubMed ID: 23706552
[TBL] [Abstract][Full Text] [Related]
19. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
20. [Testosterone therapy].
Diemer T; Hauptmann A; Wagenlehner FM
Urologe A; 2016 Apr; 55(4):539-48; quiz 549-50. PubMed ID: 27067659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
